Increased confidence in Eventide Healthcare & Life Sciences’ research edge in the healthcare space merits a Process Pillar upgrade to Above Average from Average, while its People Pillar remains at Above Average. This strategy combines ESG and faith-based criteria with rigorous fundamental analysis to identify high-quality healthcare companies trading below their intrinsic value. It specifically focuses on biotechnology, a segment known for high potential returns but also outsize volatility and binary risk. The team's edge lies in navigating that risk: its process is supported by extensive primary research, including engagement with industry stakeholders, medical literature, conferences, and clinical studies, as well as the expertise of dedicated portfolio managers and Ph.D.-level analysts. Additionally, the strategy’s inclusion of pharmaceutical and healthcare equipment businesses leads to a wider opportunity set, better diversification, and a more palatable performance profile than a pure biotech offering. Exclusionary screens have a limited impact on the investment universe, helping preserve a broad opportunity set within the sector.
Process Pillar
The Process Pillar is our assessment of how sensible, clearly defined, and repeatable ETNHX’s performance objective and investment process is for both security selection and portfolio construction.
United States